OOIR: Observatory of International Research

Papers

(The H4-Index of Current Oncology Reports is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	164
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	162
New Developments in VHL-Associated Neuroendocrine Neoplasms	128
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	114
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	86
Immunotherapy in Biliary Tract Cancers: Where Are We?	78
Brain Prehabilitation for Oncologic Surgery	64
Surgical Management of Melanoma: Advances and Updates	59
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	51
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	51
NRG1 Fusions: The New Kid on the Block	47
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	45
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	44
Treatment of Metastatic Melanoma in the Elderly	41
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	41
Management of In-Transit Metastases	40
Fatty Acid Metabolism and Cancer Immunotherapy	40
Management of Upper Tract Urothelial Carcinoma	40
Head and Neck Mucosal Melanoma: Where Are We Now?	39
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	38
Surgical Stress and Cancer Progression: New Findings and Future Perspectives	36
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	35
Engineered T Cells: CAR T Cell Therapy and Beyond	33
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	33
Anti-PD-1: When to Stop Treatment	33

The Microbiome in Advanced Melanoma: Where Are We Now?	33
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	32
An Overview of Angiogenesis in Bladder Cancer	32
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	32
Cellular Therapy in NSCLC: Between Myth and Reality	31
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	30
The Difficult Airway in Patients with Cancer	30
Current Trends and Challenges of Microbiome Research in Prostate Cancer	30